Haselmeier and Common Sensing Enter Connected Injectable Medicine Collaboration

CAMBRIDGE, United States, May 2, 2018 – Haselmeier, a Swiss-based developer and manufacturer of innovative self-injection devices, and Common Sensing, a Cambridge-based smart injector monitoring and support solutions company, today announced a partnership agreement to develop smart connected monitoring and support solutions for users of injectable medicines.
For more Information

Clinical Trials

Injection Pen for clinical Trials

The disposable D-Flex Pen offers a new technical development for subcutaneous self-medication – even for clinical trials. The new drug delivery device gives pharmaceuticals a matching platform for clinical trials at a very early stage of medicine development.

30 years of experience

Paul Jansen as Senior Advisor

The well-respected and listened to member of the medical device community, Paul Jansen, started in his new position as senior advisor on February 1, 2017.

Haselmeier D-Flex Pen

May we introduce: the award-winning D-Flex. Just one.

The D-Flex is the disposable pen for the use with 3 ml cartridges. It closes the gap between fixed-dose pens which only allow a single fixed dose, and variable-dose pens where the dose can be finely adjusted by the patient.